A biomarker catalog for inflammatory bowel disease medications
Hart, T.; West, K.; Preto, A. J.; Domingo-Fernandez, D.
Show abstract
IntroductionInflammatory bowel disease (IBD), which includes Crohns disease (CD) and ulcerative colitis (UC), is a multifaceted illness with diverse manifestations. Current treatment strategies are inadequate, with low response rates, secondary loss of response, and serious side effects. MethodsWe leveraged a large multiomics dataset (SPARC IBD) to compile a catalog of biomarkers for (i) disease severity, (ii) medication use, and (iii) response to a medication. Data were stratified based on IBD subtype (UC and CD) and tissue type; biomarker associations were identified using mixed-effects models to account for multiple medication groups, disease status (e.g., remission, active, etc.), and repeated sampling. ResultsOur catalog lists thousands of potential biomarkers for disease severity (9,657), medication effect (293), and medication response (59). These biomarkers, both known and novel, span multiple diagnoses, tissues, and medications. ConclusionThese therapy-specific signatures will enable tracking of treatment response, diagnosis of disease severity, and identification of new therapeutic targets.
Matching journals
The top 10 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Reference-guided Genome Assembly of Long Non-coding RNA Transcripts reveals Target Genes Associated With Crohn's Disease 93%
- Linking Gene Expression to Clinical Outcomes in Pediatric Crohn's Disease Using Machine Learning 92%
- Microbiota-Short Chain Fatty Acid Relationships and Microbial Substrate Preferences Vary Across the Spectrum of Irritable Bowel Syndrome (IBS) 91%
Similar papers in this journal
- Gut microbiota transplantation drives the adoptive transfer of colonic genotype-phenotype characteristics between mice lacking catestatin and their wild type counterparts 92%
- An IBD-associated pathobiont synergises with NSAID to promote colitis which is blocked by NLRP3 inflammasome and Caspase-8 inhibitors 92%
- A history of repeated antibiotic usage leads to microbiota-dependent mucus defects 92%
Similar papers in this journal
- Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19 92%
- Treatment with commonly used antiretroviral drugs induces a type I/III interferon signature in the gut in the absence of HIV infection 92%
- Dynamics of gut microbiome – mediated bile acid metabolism in progression to islet autoimmunity 91%
Similar papers in this journal
- Predictive Metagenomic Analysis of Autoimmune Disease Identifies Robust Autoimmunity and Disease Specific Microbial Signatures 91%
- Digital Therapeutics Care Utilizing Genetic and Gut Microbiome Signals for the Management of Functional Gastrointestinal Disorders: Results from a Preliminary Retrospective Study 91%
- Higher prevalence of Bacteroides fragilis in Crohn's disease exacerbations and strain-dependent increase of epithelial resistance 89%
Similar papers in this journal
- Improved diagnosis of inflammatory bowel disease and prediction and monitoring of response to anti-TNF alpha treatment based on measurement of signal transduction pathway activity 95%
- Enteric coronavirus infection and treatment modeled with an immunocompetent human intestine-on-a-chip 88%
- Prenatal methadone exposure selectively alters protein expression in primary motor cortex: implications for synaptic function 88%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.